ZOLL MEDICAL COMPLETES ACQUISITION OF CARDIAC SCIENCE


ZOLL MEDICAL COMPLETES ACQUISITION OF CARDIAC SCIENCE
Expands Solutions for Cardiac Arrest Victims in the Community

August 27, 2019─Chelmsford, Mass.–ZOLL Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously announced acquisition of Cardiac Science® Corporation, a leading provider of automated external defibrillators (AEDs), related services, and accessories.

“We are excited about the alignment of our two companies and our combined ability to place lifesaving technology into the hands of more lay rescuers and first responders during medical emergencies,” said Elijah A. White, President of ZOLL Resuscitation. “This acquisition fits well into ZOLL’s vision of providing integrated, innovative acute and resuscitation care for all.”

“Cardiac Science and ZOLL both provide proven AED solutions to broad segments of the public safety market,” he explained. “With Cardiac Science now part of ZOLL, we’ll be able to offer our customers more choices and a stronger AED program management infrastructure to ensure that both families of AEDs are ready when needed.”

Cardiac Science will become part of ZOLL’s Resuscitation division, headquartered in Chelmsford, Massachusetts, but will continue manufacturing in the Deerfield, Wisconsin facility. ZOLL will continue to promote, market, and supply the Powerheart® line of AEDs and Rescue Ready® services as well as ZOLL AEDs and PlusTrac™ program management.

Our First Priority
Our first priority is to you, our trusted customers who purchase Zoll and Cardiac Science products. Please view our the Acquisition FAQs for more information at this time.

About Sudden Cardiac Arrest

Sudden cardiac arrest (SCA) is an abrupt disruption of the heart’s function that causes a lack of blood flow to vital organs. SCA claims more than 350,000 lives each year in the U.S. and is the leading cause of unexpected death in the world. For a victim of SCA, timing is critical to survival. If a victim does not receive CPR and early defibrillation from an AED, chances of survival decrease 10% with each passing minute.

About Cardiac Science Corporation

Cardiac Science Corporation develops, manufactures, and markets automated external defibrillators (AEDs) and related parts, components, and accessories. The company also provides a comprehensive portfolio of training, maintenance, and support services for AED customers. Cardiac Science has operations in North America, Europe, and Asia and has an installed base of over 500,000 units in nearly 100 countries worldwide. For information, call 1.800.426.0337 or contact info@cardiacscience.com.

About ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care. For more information, visit www.zoll.com.

About Asahi Kasei

The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the materials, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.
For more information, visit www.asahi-kasei.co.jp/asahi/en/.